115 related articles for article (PubMed ID: 3730622)
1. Decreased NK activity in hairy cell leukemia (HCL): an analysis at the cellular level.
Fontana L; De Rossi G; De Sanctis G; Ensoli F; Lopez M; Annino L; Mandelli F
Blut; 1986 Aug; 53(2):107-13. PubMed ID: 3730622
[TBL] [Abstract][Full Text] [Related]
2. Severe deficiency of natural killer activity in the peripheral blood of patients with hairy cell leukemia.
Ruco LP; Procopio A; Maccallini V; Calogero A; Uccini S; Annino L; Mandelli F; Baroni CD
Blood; 1983 Jun; 61(6):1132-7. PubMed ID: 6220750
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms accounting for the defective natural killer activity in patients with hairy cell leukemia.
Trentin L; Zambello R; Agostini C; Ambrosetti A; Chisesi T; Raimondi R; Bulian P; Pizzolo G; Semenzato G
Blood; 1990 Apr; 75(7):1525-30. PubMed ID: 2317560
[TBL] [Abstract][Full Text] [Related]
4. Natural killer lymphocytes in hairy cell leukemia: presence of phenotypically identifiable cells with defective functional activity.
Smith BR; Rosenthal DS; Ault KA
Exp Hematol; 1985 Mar; 13(3):189-93. PubMed ID: 3884356
[TBL] [Abstract][Full Text] [Related]
5. Lack of natural killer cell activity in hairy cell leukemia patients and partial restoration with interleukin-2.
Hooper WC; Barth RF; Shah NT
Cancer; 1986 Mar; 57(5):988-93. PubMed ID: 3484663
[TBL] [Abstract][Full Text] [Related]
6. Natural killer cell function and malignant cell phenotype in hairy cell leukaemia.
Ogmundsdóttir HM; Thorsteinsson L; Sigfússon A; Sveinsdóttir S; Björnsson S; Eyjólfsson G; Jóhannesson GM; Jensson O
APMIS; 1992 Jan; 100(1):10-20. PubMed ID: 1536717
[TBL] [Abstract][Full Text] [Related]
7. Hairy cell leukaemia: observations on natural killer activity in different clinical stages of the disease.
Demeter J; Pálóczi K; Lehoczky D; Benczúr M
Br J Haematol; 1989 Feb; 71(2):239-44. PubMed ID: 2923810
[TBL] [Abstract][Full Text] [Related]
8. Lymphocytes from patients with hairy cell leukaemia enable the distinction of two separate subpopulations of activated lymphocyte killer cells generated in mixed lymphocyte culture.
Werkmeister JA; Boyd AW; Triglia T; Burns GF
Clin Exp Immunol; 1985 Jul; 61(1):103-8. PubMed ID: 2931219
[TBL] [Abstract][Full Text] [Related]
9. Whole blood assay for NK activity in splenectomized and non-splenectomized hairy cell leukemia patients during IFN-alpha-2b treatment.
Nielsen B; Hokland P; Ellegaard J; Hasselbalch H; Hokland M
Leuk Res; 1989; 13(6):451-6. PubMed ID: 2770329
[TBL] [Abstract][Full Text] [Related]
10. Deficiency of natural killer activity, but not of natural killer binding, in patients with lymphoadenopathy syndrome positive for antibodies to HTLV-III.
Fontana L; Sirianni MC; de Sanctis G; Carbonari M; Ensoli B; Aiuti F
Immunobiology; 1986 Jul; 171(4-5):425-35. PubMed ID: 3017846
[TBL] [Abstract][Full Text] [Related]
11. Surface markers of human natural killer cells as analyzed in a modified single cell cytotoxicity assay on poly-L-lysine coated cover slips.
Vargas-Cortes M; Hellström U; Perlmann P
J Immunol Methods; 1983 Aug; 62(1):87-99. PubMed ID: 6348173
[TBL] [Abstract][Full Text] [Related]
12. Hairy cell leukemia: absence of natural killer activity and of interleukin 1 release in OKM-1+ spleen hairy cells.
Ruco LP; Stoppacciaro A; Valtieri M; Procopio A; Uccini S; Baroni CD
Clin Immunol Immunopathol; 1983 Jan; 26(1):47-55. PubMed ID: 6603305
[TBL] [Abstract][Full Text] [Related]
13. The beneficial effects of alpha-interferon in hairy cell leukemia are not attributable to NK cell-mediated cytotoxicity.
Griffiths SD; Cawley JC
Leukemia; 1987 Apr; 1(4):372-6. PubMed ID: 3669763
[TBL] [Abstract][Full Text] [Related]
14. Interleukin 12 augments natural killer-cell mediated cytotoxicity in hairy cell leukemia.
Bigda J; Mysliwska J; Dziadziuszko R; Bigda J; Mysliwski A; Hellmann A
Leuk Lymphoma; 1993 May; 10(1-2):121-5. PubMed ID: 8104069
[TBL] [Abstract][Full Text] [Related]
15. Rapid restoration of natural killer activity following treatment with 2-chlorodeoxyadenosine in 22 patients with hairy-cell leukemia.
Lauria F; Rondelli D; Raspadori D; Benfenati D; Tura S
Eur J Haematol; 1994 Jan; 52(1):16-20. PubMed ID: 7905425
[TBL] [Abstract][Full Text] [Related]
16. Hairy cell leukemia cells are relatively NK-insensitive targets.
Starling GC; Nimmo JC; Hart DN
Pathology; 1988 Oct; 20(4):361-5. PubMed ID: 2977221
[TBL] [Abstract][Full Text] [Related]
17. Defective natural cytotoxicity in patients with cancer: normal number of effector cells but decreased recycling capacity in patients with advanced disease.
Steinhauer EH; Doyle AT; Reed J; Kadish AS
J Immunol; 1982 Nov; 129(5):2255-9. PubMed ID: 7119445
[TBL] [Abstract][Full Text] [Related]
18. Increase of NK cell-mediated cytotoxicity of hairy cell leukemia patients after splenectomy.
Bigda J; Myśliwska J; Baran V; Zoltowska A; Hellmann A
Eur J Haematol; 1989 Jul; 43(1):78-9. PubMed ID: 2767244
[No Abstract] [Full Text] [Related]
19. Natural killer cells in normal pregnancy: analysis using monoclonal antibodies and single-cell cytotoxicity assays.
Gregory CD; Lee H; Rees GB; Scott IV; Shah LP; Golding PR
Clin Exp Immunol; 1985 Oct; 62(1):121-7. PubMed ID: 3864569
[TBL] [Abstract][Full Text] [Related]
20. Detection of NK activity and antibody-dependent cellular cytotoxicity of lymphocytes by human tumor clonogenic assay--its correlation with the 51Cr-release assay.
Nomori H; Saijo N; Fujita J; Hyoi M; Sasaki Y; Shimizu E; Kanzawa F; Inomata M; Hoshi A
Int J Cancer; 1985 Apr; 35(4):449-55. PubMed ID: 3872846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
